Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Heterogeneous safety profiles for dermatological and endocrine AEs
Not all GLP1-RA are the same
- Neuroendocrine tumors
Precision medicine in diagnostics and therapy
- Irritable Bowel Syndrome
Functional disorder of gut-brain interaction – a biopsychosocial concept
- GLP1 receptor agonists
Positive influence on substance use and addiction
- Sleep apnea and cardiovascular diseases
Breathless through the night
- Diagnostics, differentiation and multimodal therapy
Vulvar diseases and vulvodynia
- From symptom to diagnosis
Abdominal pain – Prostate lipoma
- Acute pulmonary embolism: new AHA/ACC guideline